SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,564 | +141.0% | 56,739 | +162.8% | 0.02% | +166.7% |
| Q2 2023 | $649 | -63.8% | 21,594 | -56.3% | 0.01% | -72.7% |
| Q1 2023 | $1,792 | +60.7% | 49,464 | +58.1% | 0.02% | +37.5% |
| Q4 2022 | $1,115 | -99.9% | 31,281 | -40.5% | 0.02% | -15.8% |
| Q3 2022 | $1,780,000 | +420.5% | 52,598 | +344.2% | 0.02% | +375.0% |
| Q2 2022 | $342,000 | -85.4% | 11,841 | -85.3% | 0.00% | -71.4% |
| Q4 2021 | $2,349,000 | +312.1% | 80,576 | +277.0% | 0.01% | +366.7% |
| Q3 2021 | $570,000 | +68.1% | 21,374 | +49.7% | 0.00% | -70.0% |
| Q2 2020 | $339,000 | – | 14,282 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |